PRN: High Potency Active Pharmaceutical Ingredients (APIs) Market to Reach $34.8 Billion by 2025: Supportive Government Regulations Will Help Drive Growth

22/ago/2017 16:45:08 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

High Potency Active Pharmaceutical Ingredients (APIs) Market to Reach $34.8 Billion by 2025: Supportive Government Regulations Will Help Drive Growth

 
[22-August-2017]
 

DUBLIN, August 22, 2017 /PRNewswire/ --

The "High Potency Active Pharmaceutical Ingredients (APIs) Market, 2014-2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to this new report. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for high potency active pharmaceutical ingredients (HPAPIs) over the forecast period.

In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.

Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it.

Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment.

Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development.

Companies Mentioned

  • Eli Lily and Company
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Roche Diagnostics Ltd.
  • Sanofi
  • Hospira, Inc.
  • BASF SE
  • Covidien plc
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sigma Aldrich Corporation
  • Bayer AG
  • Carbogen Amcis AG
  • Lonza
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1 Methodology and Scope

2. Executive Summary

3. HPAPI Market Variables, Trends & Scope

4. HPAPI Market: Product Estimates & Trend Analysis

5. HPAPI Market: Manufacturer Estimates & Trend Analysis

6. HPAPI Market: Drug Type Estimates & Trend Analysis

7. HPAPI Market: Therapeutic Application Estimates & Trend Analysis

8. HPAPI Market: Regional Estimates & Trend Analysis, by Product, Manufacturer, Drug Type, and Therapeutic Application

9. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/2s5hbb/high_potency

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl